---
title: "Case Study: Deviation Backlog Reduction, CAPA Management, and Long-Term Staff Augmentation"
description: Learn how The FDA Group helped a multinational pharmaceutical manufacturer reduce its deviation backlog, manage CAPAs, and augment internal roles.
image: https://www.thefdagroup.com/hubfs/fda-CaseStudy-DeviationBacklogReduction-Cover.jpg
---

| ![](https://www.thefdagroup.com/hubfs/fda-CaseStudy-DeviationBacklogReduction-Cover.jpg) | Get our free case study # Deviation Backlog Reduction, CAPA Management, and Long-Term Staff Augmentation From August 2020 to December 2020, and continuing through an extension to August 2021, The FDA Group was pleased to support a large multinational pharmaceutical company’s QMS remediation efforts. This project principally included deviation and CAPA backlog activities, significant corrective and preventive remediation throughout the quality system, and extended support to assist in staff onboarding, training, and maintaining the continuity of improvements made across the QMS. **Read our free case study and learn:** - What prompted a major pharmaceutical company to seek support for significant QMS remediation and deviation backlog handling - How The FDA Group worked closely with the company's quality and compliance personnel to find perfect-match experts to augment their staff through a convenient, flexible, cost-effective full-time contracting arrangement - How the project success evolved into full-time augmented QA leadership roles that continue to reduce overhead while maximizing skillset availability in a competitive labor environment **Download the free case study and get a real-world look at smart staff augmentation in action. 👇** [Get the case study »](https://www.thefdagroup.com/case-study-deviation-backlog-reduction#) |
| --- | --- |
| [![FDA logo](https://www.thefdagroup.com/hubfs/template_2019/img/logo.svg)](https://www.thefdagroup.com/) The FDA Group, LLC will not be liable for any errors or omissions in this information nor for the availability of this information. The owner will not be liable for any losses, injuries, or damages from the display or use of this information. [Privacy Policy](https://www.iubenda.com/privacy-policy/7819312) |  |

### Get the Case Study

![](https://dc.ads.linkedin.com/collect/?pid=19851&fmt=gif)